Cargando…
Cell-Based Therapeutic Approaches for Cystic Fibrosis
Cystic Fibrosis (CF) is a chronic autosomal recessive disease caused by defects in the cystic fibrosis transmembrane conductance regulator gene (CFTR). Cystic Fibrosis affects multiple organs but progressive remodeling of the airways, mucus accumulation, and chronic inflammation in the lung, result...
Autores principales: | Duchesneau, Pascal, Waddell, Thomas K., Karoubi, Golnaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432606/ https://www.ncbi.nlm.nih.gov/pubmed/32718005 http://dx.doi.org/10.3390/ijms21155219 |
Ejemplares similares
-
Interrupted reprogramming of alveolar type II cells induces progenitor-like cells that ameliorate pulmonary fibrosis
por: Guo, Li, et al.
Publicado: (2018) -
Generation of Induced Progenitor-like Cells from Mature Epithelial Cells Using Interrupted Reprogramming
por: Guo, Li, et al.
Publicado: (2017) -
Novel therapeutic approaches for the management of cystic fibrosis
por: Jaques, Ryan, et al.
Publicado: (2020) -
Current strategies and opportunities to manufacture cells for modeling human lungs
por: Varma, Ratna, et al.
Publicado: (2020) -
Cystic fibrosis: current therapeutic targets and future approaches
por: Rafeeq, Misbahuddin M., et al.
Publicado: (2017)